ArticlePDF Available

Global, Regional, and National Incidence and Mortality of Neonatal Preterm Birth, 1990-2019

Authors:

Abstract and Figures

Importance: Preterm birth complications are the leading cause of death in children younger than 5 years worldwide. Despite advancing knowledge of risk factors and mechanisms related to preterm labor, the preterm birth rate has risen in most industrialized countries. Moreover, the burden of neonatal preterm birth remains unclear across the world. Objective: To determine the trends in incidence and mortality of neonatal preterm birth at the global, regional, and national levels to quantify its burden from 1990 to 2019 using data from the 2019 Global Burden of Disease study. Design, setting, and participants: Annual incident cases, deaths, age-standardized incidence rates (ASIRs), and age-standardized mortality rates (ASMRs) of neonatal preterm birth between 1990 and 2019 were collected from the 2019 Global Burden of Disease study. The percentage of relative changes in incident cases and deaths as well as the estimated annual percentage changes (EAPCs) of ASIRs and ASMRs were calculated to quantify their temporal trends. Correlations of EAPC of ASIRs and ASMRs with sociodemographic index (SDI) and universal health coverage index were evaluated by Pearson correlation analyses. Exposures: Infants born alive before 37 completed weeks of gestation between 1990 and 2019. Main outcomes and measures: Incident cases, deaths, ASIRs, and ASMRs of neonatal preterm birth. Results: Globally, the incident cases of neonatal preterm birth decreased by 5.26% from 16.06 million in 1990 to 15.22 million in 2019, and the deaths decreased by 47.71% from 1.27 million in 1990 to 0.66 million in 2019. The overall ASIR (EAPC = -0.19 [95% CI, -0.27 to -0.11]) and ASMR (EAPC = -2.09 [95% CI, -1.99 to -2.20]) decreased in this period. The ASIR of neonatal preterm birth increased by a mean of 0.25% (95% CI, 0.13%-0.38%) in high-SDI regions from 1990 to 2019. The ASMR of neonatal preterm birth increased by a mean of 2.09% (95% CI, 1.99%-2.20%) in Southern Sub-Saharan Africa in this period. A positive correlation was observed between EAPC of ASIR and SDI or universal health coverage index in 2019, while a negative correlation was observed between EAPC in ASMR and SDI or universal health coverage index in 2019 at national levels. Conclusions and relevance: Preterm birth remains a crucial issue in children worldwide, with an increasing trend in ASIR in high-SDI regions and in ASMR in Southern Sub-Saharan Africa between 1990 to 2019. Efforts to reduce both the incidence and mortality of preterm births are essential.
Content may be subject to copyright.
Global, Regional, and National Incidence and Mortality
of Neonatal Preterm Birth, 1990-2019
Guiying Cao, PhD; Jue Liu, PhD; Min Liu, PhD
IMPORTANCE Preterm birth complications are the leading cause of death in children younger
than 5 years worldwide. Despite advancing knowledge of risk factors and mechanisms related
to preterm labor, the preterm birth rate has risen in most industrialized countries. Moreover,
the burden of neonatal preterm birth remains unclear across the world.
OBJECTIVE To determine the trends in incidence and mortality of neonatal preterm birth at
the global, regional, and national levels to quantify its burden from 1990 to 2019 using data
from the 2019 Global Burden of Disease study.
DESIGN, SETTING, AND PARTICIPANTS Annual incident cases, deaths, age-standardized
incidence rates (ASIRs), and age-standardized mortality rates (ASMRs) of neonatal preterm
birth between 1990 and 2019 were collected from the 2019 Global Burden of Disease study.
The percentage of relative changes in incident cases and deaths as well as the estimated
annual percentage changes (EAPCs) of ASIRs and ASMRs were calculated to quantify their
temporal trends. Correlations of EAPC of ASIRs and ASMRs with sociodemographic index
(SDI) and universal health coverage index were evaluated by Pearson correlation analyses.
EXPOSURES Infants born alive before 37 completed weeks of gestation between 1990 and
2019.
MAIN OUTCOMES AND MEASURES Incident cases, deaths, ASIRs, and ASMRs of neonatal
preterm birth.
RESULTS Globally, the incident cases of neonatal preterm birth decreased by 5.26% from
16.06 million in 1990 to 15.22 million in 2019, and the deaths decreased by 47.71% from 1.27
million in 1990 to 0.66 million in 2019. The overall ASIR (EAPC = −0.19 [95% CI, −0.27 to
−0.11]) and ASMR (EAPC = −2.09 [95% CI, −1.99 to −2.20]) decreased in this period. The ASIR
of neonatal preterm birth increased by a mean of 0.25% (95% CI, 0.13%-0.38%) in high-SDI
regions from 1990 to 2019. The ASMR of neonatal preterm birth increased by a mean of
2.09% (95% CI, 1.99%-2.20%) in Southern Sub-Saharan Africa in this period. A positive
correlation was observed between EAPC of ASIR and SDI or universal health coverage index
in 2019, while a negative correlation was observed between EAPC in ASMR and SDI or
universal health coverage index in 2019 at national levels.
CONCLUSIONS AND RELEVANCE Preterm birth remains a crucial issue in children worldwide,
with an increasing trend in ASIR in high-SDI regions and in ASMR in Southern Sub-Saharan
Africa between 1990 to 2019. Efforts to reduce both the incidence and mortality of preterm
births are essential.
JAMA Pediatr. doi:10.1001/jamapediatrics.2022.1622
Published online May 31, 2022.
Supplemental content
Author Affiliations: Department of
Epidemiology and Biostatistics,
School of Public Health, Peking
University,Beijing, China.
Corresponding Author: Min Liu,
PhD, Department of Epidemiology
and Biostatistics, School of Public
Health, Peking University, No. 38
Xueyuan Road, Haidian District,
Beijing 100191, China (liumin@
bjmu.edu.cn).
Research
JAMA Pediatrics | Original Investigation
(Reprinted) E1
Downloaded From: https://jamanetwork.com/ on 06/02/2022
Preterm birth is defined as infants born alive before 37
completed weeks of gestation by the World Health Or-
ganization (WHO).
1
Globally, it is estimated that 14.84
million infants were born preterm in 2014, and this number is
rising.
2
The preterm birth rate is 10.6%worldwide, ranging from
8.7% to 13.4% of infants born across regions.
2
In addition, the
preterm birth rate varies significantly across countries, with
an increasing trend in most industrialized countries.
3
For ex-
ample, the preterm birth rate in the US increased from 9.5%
in 1981 to 12.7% in 2005.
3
Preterm birth is truly a global prob-
lem, despite more than 60% of preterm births occuring in Africa
and South Asia.
1
Preterm infants are particularly vulnerable to complica-
tions due to impaired respiration, difficulty in feeding, poor
body temperature regulation, and high risk of infection.
4
Pre-
term birth complications are the leading cause of death in chil-
dren younger than 5 years worldwide and were responsible
for approximately 1 million deaths in 2015.
1
Global efforts to
further reduce mortality in children younger than 5 years de-
mand urgent action based on the data of incidence and mor-
tality of preterm birth at regional and national levels as well
as their associated factors. To our knowledge, there is cur-
rently no study to systematically clarify both the incidence and
mortality of neonatal preterm birth at the global, regional, and
national levels, as well as their association with socioeco-
nomic status. Therefore, we retrieved detailed data on the
incidence and mortality of neonatal preterm birth and socio-
economic status from the 2019 Global Burden of Disease (GBD)
study to determine the global incidence and mortality of
neonatal preterm birth and their associations with socioeco-
nomic status at the national level to provide a more compre-
hensive perspective to make global and regional targeted in-
terventions and health care policies for the prevention and
control of neonatal preterm birth.
Methods
Data Source
The 2019 GBD study modeled nonfatal disease burden using
DisMod-MR version 2.1, a meta-analysis tool that uses a
compartmental model structure with a series of differential
equations that synthesize sparse and heterogeneous epide-
miologic data for nonfatal diseases, including neonatal
disorders.
5
In addition, the GBD study used standardized tools
to generate estimates for the incidence and mortality of most
diseases by age, sex, location, and year.
6,7
In the GBD study,
preterm birth is defined as infants born alive before 37 weeks
of pregnancy according to the WHO.
8,9
The detailed methods
of the modeling strategy and alternative approaches for esti-
mating neonatal preterm birth have been reported in previ-
ous studies.
5-7
The study did not involve human participants
and/or animals; therefore,no ethic s approvalor informed con-
sent was needed.
This study used data of annual incident cases, deaths, age-
standardized incidence rates (ASIRs), and age-standardized
mortality rates (ASMRs) of neonatal preterm birth from 1990
to 2019 by sex, age, and location, collected from the Global
Health Data Exchange query tool.
10
Data were available from
a total of 204 countries and territories, and these were catego-
rized into 5 regions in terms of sociodemographic index (SDI)
and 21 GBD regions according to geographical contiguity. Data
on sociodemographic states, including SDI and universal health
coverage index (UHCI), in 204 countries and territories used
in this study were also collected from the Global Health Data
Exchange query tool.
9
SDI
The SDI is a composite indicator of development status strongly
correlated with health outcomes.
9
It is the geometric mean of
0 to 1 indices of lag distributed income per capita, mean years
of schooling for individuals 15 years and older, and total fer-
tility rate for individuals youngerthan 25 years. A loc ationw ith
an SDI of 0 indicates a theoretical minimum level of develop-
ment status relevant to health outcomes, while a location with
an SDI of 1 indicates a theoretical maximum level.
9
The SDIs
of 204 countries and territories in 2019 are shown in eTable 1
in the Supplement.
UHCI
The UHCI developed following GBD 2019 comprises 23 indi-
cators drawn across a range of health care service areas and is
meant to represent health care needs over the life course.
11
The
indicators of UHCI involved either direct measures of inter-
vention coverage (eg, antiretroviral therapy coverage) or out-
come-based indicators, such as mortality-to-incidence ra-
tios, to approximate access to quality care.
12
The UHCI
indicators are reported on a scale of 0 to 100.
12
The UHCIs of
204 countries and territories in 2019 are shown in eTable 1 in
the Supplement.
Statistical Analysis
We calculated the percentage of relative changes in incident
cases and deaths of neonatal preterm birth and the estimated
Key Points
Question What is the burden of neonatal preterm birth at the
global, regional, and national levels?
Findings In this cross-sectional study using data from the Global
Burden of Disease study, incident cases and deaths of neonatal
preterm birth, overall age-standardized incidence rates (ASIRs),
and age-standardized mortality rates (ASMRs) of neonatal preterm
birth decreased from 1990 to 2019; however, ASIRs and ASMRs
increased in some regions with high sociodemographic index
regions and in Southern Sub-Saharan Africa, respectively. There
was a positive correlation between estimated annual percentage
change of ASIR and sociodemographic index or universal health
coverage index in 2019, while there was a negative correlation
between estimated annual percentage change in ASMR and
sociodemographic index or universal health coverage index in
2019 at the national level.
Meaning Preterm birth remains a crucial issue in children
worldwide and discovery research into the underlying
mechanisms of neonatal preterm birth and the development of
innovative interventions is urgent.
Research Original Investigation Global, Regional, and National Incidence and Mortality of Neonatal Preterm Birth, 1990-2019
E2 JAMA Pediatrics Published online May 31, 2022 (Reprinted) jamapediatrics.com
Downloaded From: https://jamanetwork.com/ on 06/02/2022
annual percentage changes (EAPCs) of ASIRs and ASMRs to
quantify the trends in incidence of neonatal preterm birth. To
compare the incidence and mortality rates of neonatal pre-
term birth across different populations, the ASIRs and ASMRs
were carried out by applying the age-specific rates for each
location, sex, and year to a GBD world standard population to
adjust for potential confounding of age structure.
13
The per-
centage of relative changes in incident cases of neonatal
preterm birth from 1990 to 2019 was calculated by the equa-
tion: percentage of relative changes = (incident cases in
2019 incident cases in 1990 / incidentc ases in 1990) × 100%.
The percentage of relative changes in deaths of neonatal
preterm birth were calculated using a similar equation. The
EAPC is a summary and widely used measure of the age-
standardized rate trend over a specified time interval. A
regression line was fitted to the natural logarithm of the
age-standardized rate, ie, y = α + βx + ε, where y = ln (age-
standardized rate) and x = calendar year. The EAPC was cal-
culated as 100 × (e
β
1) and its 95% CI was calculated to re-
flect the temporal trend in age-standardized rate. The trend
in age-standardized rate is reflected in EAPC value and its 95%
CI age-standardized rate is in an upward trend when the EAPC
and the lower boundary of the 95% CI are positive; con-
versely, age-standardized rate is in a downward trend when
EAPC and the upper boundary of the 95% CI are negative. We
calculated the EAPCs of ASIR and ASMR of neonatal preterm
birth to reflect their temporal trends.
Moreover,the correlations of EAPC of ASIR and ASMR w ith
SDI values (2019) and UHCI (2019) in 204 countries and terri-
tories were evaluated by Pearson correlation analyses to de-
fine the potential factors affecting EAPC. The polynomial
curves were also modeled. All analyses were conducted with
SAS version 9.4 (SAS Institute) and Origin 2019b (OriginLab).
A 2-tailed Pvalue less than .05 was considered statistically
significant.
Results
Global Trend in Incidence and Mortality
of Neonatal Preterm Birth
Globally,the number of incident c ases of neonatalpreterm birth
decreased by 5.26% from 16.06 million in 1990 to 15.22 mil-
lion in 2019, and the number of deaths of neonatal preterm
birth decreased by 47.71% from 1.27 million in 1990 to 0.66 mil-
lion in 2019 (Table 1). The overall ASIR of neonatal pretermbirth
decreased in the same period (EAPC = −0.19 [95% CI, −0.27 to
−0.11]) from 244.19 per 100 000 in 1990 to 234.96 per 100 000
in 2019 (Table 2). The ASMR of neonatal preterm birth de-
creased by a mean of 2.09% (95% CI, 1.99%-2.20%) per year
in the same period (from 19.34 per 100 000 in 1990 to 10.24
per 100 000 in 2019) (Table 2).
Regional Trend in Incidence and Mortality
of Neonatal Preterm Birth
In high-SDI regions, the incident cases of neonatal preterm birth
decreased by 5.00% from 1990 to 2019 (Table 1), whereas the
ASIR of neonatal preterm birth increased in the same period
(EAPC = 0.25 [95% CI, 0.13-0.38]) from 171.30 per 100000 in
1990 to 183.62 per 100 000 in 2019 (Table 2; eFigure 1A in the
Supplement). The ASIR of neonatal preterm birth decreased
in low-, low-middle–, middle-, and middle-high–SDI regions
(Table 2; eFigure 1A in the Supplement). The number of deaths
of neonatal preterm birth decreased by more than 50% in low-
middle–, middle-, middle-high–, and high-SDI regions but in-
creased by 4.62% in low-SDI regions from 1990 to 2019
(Table 1). In low-SDIregions, the growing number of deaths of
neonatal preterm birth was derived from the increased num-
ber of deaths in nearly neonates aged 0 to 6 days (eFigure 2 in
the Supplement). The decreasing number of deaths of neona-
tal preterm birth in low-middle–, middle-, middle-high–, and
high-SDI regions was due to the gradual decrease in the num-
ber of deaths in all neonates, especially in nearly neonates aged
0 to 6 days (eFigure 2 in the Supplement). Across 5 SDI re-
gions, the deaths and ASMR of neonatal preterm birth de-
creased in all regions, with the largest decrease in both deaths
(79.31%) and ASMR (EAPC = −4.60 [95% CI, −4.75 to 4.45])
in middle-high–SDI regions (Table 1, Table 2; eFigure 1B in the
Supplement).
Across the 21 GBD regions, the incident cases of neonatal
preterm birth decreased in 66.7% of the regions (14 GBD
regions) and the deaths of neonatal preterm birth decreased
in 81.0% of the regions (17 regions) from 1990 to 2019, with
the largest decrease both in incident cases (−48.10%) and
deaths (−85.94%) in East Asia (Table 1). The nearly neonates
aged 0 to 6 days accounted for more than 85% of deaths of
neonatal preterm birth globally and approximately 90% in
Central Sub-Saharan Africa (93.57%) and Western Sub-
Saharan Africa (90.37%) in 2019 (eFigure 3 in the Supple-
ment). In addition, the proportions of deaths of neonatal pre-
term birth in 2019 were higher than 20% for late neonates
aged 7 to 28 days in Central Europe (23.74%) and postneo-
nates aged 29 to 364 days in high-income Asia Pacific
(21.88%) (eFigure 3 in the Supplement). Oceania experienced
the largest increase both in incident cases (80.72%) and
deaths (60.39%) from 1990 to 2019 (Table 1). The Caribbean
experienced the most severe threat of incidence of neonatal
preterm birth, with approximately 3 neonatal preterm births
of 1000 populations (ASIR: 314.89 per 100 000) in 2019, fol-
lowed by South Asia (ASIR in 2019: 292.10 per 100 000). For
the mortality of neonatal preterm birth, Western Sub-Saharan
Africa experienced the most severe threat (ASMR: 18.14 per
100 000) in 2019, followed by South Asia (ASMR in 2019:
14.56 per 100 000). The trends in ASIRs of neonatal preterm
birth were heterogeneous across the 21 GBD regions from
1990 to 2019, with the highest increasing trend in high-
income Asia Pacific (EAPC = 0.46 [95% CI, 0.36-0.56]), Cen-
tral Latin America (EAPC = 0.30 [95% CI, 0.26-0.34]), and
Australasia (EAPC = 0.28 [95% CI, 0.17-0.39]) and was stable
in Western Europe and Tropical Latin America (Table 2).
Nearly half of the GBD regions had a decreasing trend in ASIRs
of neonatal preterm birth, such as Andean Latin America, East
Asia, and South Asia (Table 2). The ASMR of neonatal preterm
birth decreased in all GBD regions except Southern Sub-
Saharan Africa (EAPC = 0.62 [95% CI, 0.20-1.03]) from 1990
to 2019 (Table 2).
Global, Regional, and National Incidence and Mortality of Neonatal Preterm Birth, 1990-2019 Original Investigation Research
jamapediatrics.com (Reprinted) JAMA Pediatrics Published online May 31, 2022 E3
Downloaded From: https://jamanetwork.com/ on 06/02/2022
National Trend in Incidence and Mortality
of Neonatal Preterm Birth
For 204 countries and territories, the absolute number of
incident cases of neonatal preterm birth in India (3.10 mil-
lion) and Pakistan (1.04 million) accounted for approxi-
mately one-third of the global incident cases (15.22 million)
in 2019 (eTable 2 in the Supplement). The country with the
most pronounced increase in incident cases of neonatal pre-
term birth was Niger (182.10%), followed by Qatar (176.95%)
(eTable 2 in the Supplement;Figure 1A). The ASIR varies
considerably across the world, with the largest ASIR in
Yemen (545.07 per 100000), followed by Niger (429.64 per
100 000) and Afghanistan (419.12 per 100 000) in 2019
(eTable 2 in the Supplement; Figure 1B). The ASIRs were
deemed to be in a decreasing trend in 101 countries or territo-
ries, with the largest decrease in Mozambique (EAPC = −1.82
[95% CI, −2.05 to −1.58]) (eTable 2 in the Supplement;
Figure 1C). The ASIRs were deemed to be in an increasing
trend in 78 countries or territories, with the largest increase
in Greece (EAPC = 3.91 [95% CI, 3.65-4.18]), followed by
Table 1. Incident Cases and Deaths of Neonatal Preterm Birth in 1990 and 2019 and TheirChange Trends From 1990 to 2019
Characteristic
1990 2019
Relative change,
1990-2019
Incident cases, No.
×10
5
(95% UI)
Deaths, No. × 10
3
(95% UI)
Incident cases, No.
×10
5
(95% UI)
Deaths, No. × 10
3
(95% UI)
Incident
cases, % Deaths, %
Overall 160.62
(159.46-161.90)
1269.04
(1166.14-1383.98)
152.17
(151.11-153.20)
663.52 (560.96-788.95) −5.26 −47.71
Sex
Female 73.42 (72.63-74.30) 560.11 (511.83-613.97) 69.75 (68.97-70.43) 279.57 (237.91-327.32) −5.00 −50.09
Male 87.19 (86.34-88.05) 708.93 (644.55-781.04) 82.42 (81.70-83.18) 383.95 (321.74-463.85) −5.47 −45.84
SDI region
Low NA 250.36 (221.71-283.47) NA 261.93 (214.37-321.60) NA 4.62
Low-middle NA 474.63 (426.84-532.36) NA 237.06 (196.74-280.55) NA −50.05
Middle NA 376.48 (348.51-406.02) NA 124.81 (105.33-147.61) NA −66.85
Middle-high NA 135.26 (122.63-148.39) NA 27.98 (23.74-32.93) NA −79.31
High 9.72 (9.63-9.81) 31.69 (29.80-33.81) 9.11 (9.01-9.21) 11.31 (10.07-12.66) −5.00 −64.31
GBD region
Andean Latin America 1.10 (1.05-1.15) 10.93 (9.51-12.51) 1.08 (1.04-1.13) 4.08 (2.93-5.48) −1.78 −62.67
Australasia 0.22 (0.21-0.23) 0.65 (0.60-0.71) 0.27 (0.26-0.29) 0.25 (0.20-0.31) 25.30 −61.37
Caribbean 1.30 (1.26-1.34) 6.07 (5.28-6.96) 1.23 (1.18-1.27) 3.84 (2.78-5.23) −5.15 −36.68
Central Asia 1.40 (1.36-1.45) 9.34 (8.15-10.65) 1.26 (1.22-1.30) 5.66 (4.63-6.90) −10.16 −39.43
Central Europe 1.21 (1.18-1.23) 7.81 (7.36-8.29) 0.81 (0.79-0.82) 1.21 (0.92-1.52) −33.16 −84.55
Central Latin America 4.23 (4.15-4.31) 39.64 (34.90-44.39) 4.07 (3.99-4.15) 11.58 (8.85-14.60) −3.71 −70.78
Central Sub-Saharan
Africa
2.91 (2.79-3.03) 25.74 (19.70-32.96) 4.50 (4.30-4.70) 27.70 (20.75-36.42) 54.46 7.60
East Asia 19.06 (18.76-19.37) 165.47 (145.14-187.30) 9.89 (9.74-10.05) 23.27 (19.88-27.07) −48.10 −85.94
Eastern Europe 2.13 (2.10-2.16) 8.55 (7.81-9.47) 1.77 (1.75-1.80) 1.52 (1.21-1.88) −16.68 −82.22
Eastern Sub-Saharan
Africa
12.35 (12.16-12.54) 74.62 (64.54-85.04) 17.09 (16.83-17.37) 67.22 (51.93-87.25) 38.39 −9.92
High-income Asia Pacific 1.13 (1.10-1.17) 2.81 (2.50-3.26) 0.88 (0.86-0.90) 0.49 (0.42-0.56) −22.58 −82.52
High-income North
America
4.74 (4.70-4.78) 13.01 (12.37-13.74) 4.72 (4.65-4.78) 6.84 (6.21-7.58) −0.47 −47.40
North Africa and Middle
East
15.07 (14.77-15.41) 178.79 (152.22-212.21) 16.57 (16.24-16.92) 59.66 (47.21-74.22) 9.91 −66.63
Oceania 0.22 (0.21-0.23) 1.47 (1.08-1.90) 0.40 (0.37-0.42) 2.36 (1.57-3.44) 80.72 60.39
South Asia 58.10 (57.12-59.18) 438.60 (381.57-506.46) 46.85 (45.96-47.71) 233.42 (193.68-282.73) −19.37 −46.78
Southeast Asia 12.77 (12.56-12.98) 119.38 (106.73-134.46) 9.63 (9.50-9.78) 44.54 (35.85-54.34) −24.56 −62.69
Southern Latin America 0.57 (0.51-0.63) 7.36 (6.81-7.89) 0.55 (0.53-0.58) 2.31 (1.75-2.96) −2.63 −68.64
Southern Sub-Saharan
Africa
2.13 (2.09-2.17) 10.19 (8.54-11.99) 2.22 (2.17-2.26) 11.11 (8.63-14.66) 4.06 9.00
Tropical Latin America 4.14 (4.06-4.22) 47.02 (40.98-54.29) 3.71 (3.65-3.77) 11.31 (8.98-13.98) −10.38 −75.95
Western Europe 3.45 (3.38-3.52) 9.91 (9.44-10.60) 3.19 (3.12-3.27) 3.21 (2.69-3.80) −7.44 −67.65
Western Sub-Saharan
Africa
12.40 (12.27-12.54) 91.68 (78.21-105.92) 21.50 (21.23-21.78) 141.95 (114.66-175.77) 73.32 54.83
Abbreviations: GBD, Global Burden of Disease; NA, not applicable; SDI, sociodemographic index; UI, uncertainty interval.
Research Original Investigation Global, Regional, and National Incidence and Mortality of Neonatal Preterm Birth, 1990-2019
E4 JAMAPediatrics Published online May 31, 2022 (Reprinted) jamapediatrics.com
Downloaded From: https://jamanetwork.com/ on 06/02/2022
Table 2. ASIRs and ASMRs of Neonatal Preterm Birth in 1990 and 2019 and TheirChange Trends From 1990 to 2019
Characteristic
No. (95% UI) No. (95% CI)
1990 2019 1990-2019
ASIR per 100 000 ASMR per 100 000 ASIR per 100 000 ASMR per 100 000 EAPC of ASIR EAPC of ASMR
Overall 244.19
(242.43 to 246.14)
19.34
(17.77 to 21.09)
234.96
(233.32 to 236.54)
10.24
(8.66 to 12.18)
−0.19
(−0.27 to −0.11)
−2.09
(−2.20 to −1.99)
Sex
Female 230.89
(228.39 to 233.63)
17.65
(16.13 to 19.34)
223.07
(220.56 to 225.23)
8.94
(7.60 to 10.46)
−0.17
(−0.25 to −0.09)
−2.27
(−2.37 to −2.17)
Male 256.64
(254.13 to 259.16)
20.92
(19.02 to 23.05)
246.06
(243.90 to 248.33)
11.46
(9.60 to 13.84)
−0.20
(−0.29 to −0.12)
−1.96
(−2.06 to −1.86)
SDI region
Low 323.61
(319.41 to 328.41)
22.25
(19.71 to 25.19)
294.30
(290.56 to 297.85)
14.53
(11.89 to 17.83)
−0.32
(−0.39 to −0.25)
−1.32
(−1.38 to −1.26)
Low-middle 302.97
(298.14 to 308.52)
26.25
(23.62 to 29.45)
255.10
(250.61 to 259.26)
13.96
(11.58 to 16.52)
−0.63
(−0.72 to −0.55)
−1.94
(−2.06 to −1.82)
Middle 202.36
(200.41 to 204.43)
18.23
(16.88 to 19.66)
194.49
(192.43 to 196.65)
7.26
(6.13 to 8.58)
−0.17
(−0.20 to −0.14)
−3.02
(−3.21 to −2.83)
Middle-high 174.85
(172.29 to 177.46)
13.58
(12.32 to 14.91)
173.43
(171.06 to 175.93)
3.69
(3.13 to 4.34)
−0.09
(−0.12 to −0.06)
−4.60
(−4.75 to −4.45)
High 171.30
(169.70 to 173.01)
5.57
(5.24 to 5.94)
183.62
(181.60 to 185.68)
2.27
(2.02 to 2.54)
0.25
(0.13 to 0.38)
−2.91
(−3.00 to −2.82)
GBD region
Andean
Latin America
190.40
(181.83 to 199.54)
18.96
(16.49 to 21.71)
171.80
(164.88 to 179.11)
6.47
(4.65 to 8.69)
−0.49
(−0.54 to −0.44)
−3.56
(−3.77 to −3.35)
Australasia 142.27
(135.63 to 149.31)
4.28
(3.96 to 4.68)
153.62
(144.93 to 162.26)
1.42
(1.13 to 1.73)
0.28
(0.17 to 0.39)
−3.05
(−3.44 to −2.66)
Caribbean 298.98
(290.28 to 307.94)
14.00
(12.19 to 16.05)
314.89
(303.19 to 326.29)
9.84
(7.11 to 13.39)
0.12
(0.08 to 0.17)
−1.08
(−1.18 to −0.98)
Central Asia 149.96
(144.96 to 154.52)
9.98
(8.71 to 11.38)
139.38
(134.69 to 144.10)
6.24
(5.11 to 7.61)
−0.33
(−0.37 to −0.30)
−1.35
(−1.73 to −0.96)
Central Europe 150.55
(147.39 to 153.64)
9.67
(9.13 to 10.28)
156.82
(154.09 to 159.69)
2.33
(1.77 to 2.94)
0.12
(0.09 to 0.14)
−4.80
(−5.05 to −4.54)
Central
Latin America
177.97
(174.66 to 181.34)
16.70
(14.71 to 18.70)
192.96
(188.98 to 196.81)
5.48
(4.19 to 6.90)
0.30
(0.26 to 0.34)
−3.82
(−3.99 to −3.64)
Central
Sub-Saharan Africa
228.14
(218.60 to 237.69)
20.24
(15.48 to 25.90)
211.19
(201.75 to 220.77)
13.01
(9.75 to 17.12)
−0.23
(−0.28 to −0.17)
−1.25
(−1.42 to −1.08)
East Asia 158.41
(155.99 to 161.05)
13.74
(12.05 to 15.55)
133.45
(131.36 to 135.55)
3.12
(2.66 to 3.63)
−0.76
(−0.89 to −0.63)
−5.32
(−5.60 to −5.05)
Eastern Europe 151.65
(149.30 to 153.94)
6.06
(5.54 to 6.71)
163.86
(161.57 to 165.90)
1.40
(1.11 to 1.72)
0.36
(0.33 to 0.38)
−5.35
(−5.70 to −5.00)
Eastern
Sub-Saharan Africa
290.05
(285.64 to 294.45)
17.63
(15.25 to 20.11)
253.36
(249.44 to 257.46)
9.98
(7.71 to 12.95)
−0.48
(−0.60 to −0.35)
−1.86
(−1.96 to −1.76)
High-income
Asia Pacific
119.85
(116.45 to 123.67)
2.96
(2.62 to 3.43)
132.50
(129.47 to 135.80)
0.73
(0.64 to 0.83)
0.46
(0.36 to 0.56)
−4.27
(−4.53 to −4.02)
High-income
North America
215.56
(213.75 to 217.53)
5.90
(5.61 to 6.24)
233.97
(230.81 to 237.18)
3.38
(3.07 to 3.75)
0.26
(0.07 to 0.46)
−1.62
(−1.74 to −1.50)
North Africa
and Middle East
268.82
(263.45 to 274.73)
31.99
(27.24 to 37.99)
284.77
(279.15 to 290.74)
10.24
(8.10 to 12.73)
0.17
(0.15 to 0.20)
−3.72
(−3.83 to −3.61)
Oceania 205.92
(194.46 to 217.48)
13.87
(10.20 to 17.87)
201.21
(188.27 to 213.86)
12.01
(8.01 to 17.48)
−0.09
(−0.14 to −0.04)
−0.35
(−0.44 to −0.26)
South Asia 338.16
(332.46 to 344.46)
25.62
(22.31 to 29.57)
292.10
(286.55 to 297.51)
14.56
(12.08 to 17.64)
−0.52
(−0.60 to −0.45)
−1.64
(−1.77 to −1.50)
Southeast Asia 211.47
(208.08 to 214.93)
19.80
(17.70 to 22.30)
184.13
(181.59 to 186.93)
8.51
(6.85 to 10.38)
−0.48
(−0.49 to −0.46)
−2.84
(−2.93 to −2.74)
Southern
Latin America
113.24
(102.07 to 125.58)
14.67
(13.56 to 15.71)
119.31
(113.65 to 124.75)
4.97
(3.77 to 6.37)
0.25
(0.22 to 0.28)
−3.50
(−3.63 to −3.37)
Southern
Sub-Saharan Africa
289.10
(283.41 to 295.04)
13.85
(11.61 to 16.29)
278.40
(272.49 to 284.35)
13.95
(10.84 to 18.42)
−0.16
(−0.24 to −0.08)
0.62
(0.20 to 1.03)
Tropical
Latin America
241.73
(237.41 to 246.47)
27.50
(23.97 to 31.76)
239.95
(236.52 to 243.71)
7.30
(5.79 to 9.02)
0.02
(−0.01 to 0.04)
−4.48
(−4.59 to −4.37)
Western Europe 154.83
(151.70 to 158.09)
4.43
(4.22 to 4.74)
154.27
(150.64 to 157.90)
1.54
(1.29 to 1.83)
−0.01
(−0.04 to 0.01)
−3.45
(−3.60 to −3.31)
Western
Sub-Saharan Africa
290.02
(286.89 to 293.26)
21.51
(18.35 to 24.85)
274.32
(270.86 to 277.93)
18.14
(14.65 to 22.46)
−0.19
(−0.22 to −0.16)
−0.48
(−0.55 to −0.41)
Abbreviations: ASIR, age-standardized incidence rate; ASMR, age-standardized mortality rate; EAPC, estimated annual percentage change;
GBD, Global Burden of Disease; SDI, sociodemographic index; UI, uncertainty interval.
Global, Regional, and National Incidence and Mortality of Neonatal Preterm Birth, 1990-2019 Original Investigation Research
jamapediatrics.com (Reprinted) JAMA Pediatrics Published online May 31, 2022 E5
Downloaded From: https://jamanetwork.com/ on 06/02/2022
Bahrain (EAPC = 1.84 [95% CI, 1.69-1.99]) (eTable 2 in the
Supplement; Figure 1C). The ASIRs remained stable in 25
countries or territories, such as Afghanistan, Cameroon, and
Italy (eTable 2 in the Supplement).
The most pronounced increase in deaths of neonatal
preterm birth was observed in Niger (105.52%), followed by
Papua New Guinea (90.45%), while the most pronounced de-
crease was detected in Cook Islands (97.15%) (eTable 3 in the
Supplement;Figure 2A). The ASMR of neonatal preterm birth
varied significantly across 204 countries and territories, with
the largest ASMR in Sudan (ASMR: 25.54 per 100 000), Central
African Republic (ASMR: 23.51 per 100 000), and Mali (ASMR:
23.10 per 100 000) in 2019 (eTable 3 in the Supplement;
Figure 2B). The ASMRs were deemed to be in a decreasing trend
Figure 1. Global Trends in the Incidence of Neonatal Preterm Birth in 204 Countries and Territories
Albania:
67.71%
Greece:
EAPC
=
3.19
Niger:
182.10%
Niger:
ASIR
=
429.64
Qatar:
176.95%
Yemen:
ASIR
=
545.07
Afghanistan:
ASIR
=
419.12
Bahrain:
EAPC
=
1.84
Mozambique:
EAPC
=
–1.82
25-70 Decrease
<25 Decrease
<25 Increase
25-50 Increase
≥50 Increase
<150
150-199
200-249
250-299
≥300
<–0.4
–0.4 to –0.2
–0.2 to 0
0 to 0.2
≥0.2
ASIR in 2019 (per 100
000 population)
B
EAPC of ASIR
C
Change in incident cases, %
A
The percentage of relative change in
incident cases of neonatal preterm
birth between 1990 and 2019 (A),
age-standardized incidence rates
(ASIRs) of neonatal preterm birth in
2019 (B), and estimated annual
percentage changes (EAPCs) of ASIRs
of neonatal preterm birth from 1990
to 2019 (C) are reported.
Research Original Investigation Global, Regional, and National Incidence and Mortality of Neonatal Preterm Birth, 1990-2019
E6 JAMA Pediatrics Published online May 31, 2022 (Reprinted) jamapediatrics.com
Downloaded From: https://jamanetwork.com/ on 06/02/2022
in 186 countries or territories, with the largest decrease in Cook
Islands (EAPC = −10.23 [95% CI, −11.01 to −9.45]) (eTable 3 in
the Supplement; Figure 2C). The ASMRs were deemed to be in-
creasing in 7 countries or territories, with the largest increase
in Guam (EAPC = 1.93 [95% CI, 1.45-2.41]), followed by South
Africa (EAPC = 0.90 [95% CI, 0.30-1.50]). The ASIRs remained
stable in 11 countries or territories, such as Azerbaijan, Cote
d’Ivoire, and Burkina Faso (eTable 3 in the Supplement).
Correlations of EAPC of ASIR and ASMR With SDI and UHCI
A significant positive correlation was detected between EAPC
of ASIR of neonatal preterm birth and SDI in 2019 = 0.41;
Figure 2. Global Trends in the Mortality of Neonatal Preterm Birth in 204 Countries and Territories
Niger:
105.52%
Papua New Guinea:
90.45%
Cook Islands:
97.15%
South Africa:
EAPC
=
0.90
Guam:
EAPC
=
1.93
<2.5
2.5-4.9
5.0-7.4
7.5-9.9
≥10
80-100 Decrease 60-80 Decrease 40-60 Decrease <40 Decrease ≥0 Increase
<–4.5 –4.5 to –3.0 –3.0 to –1.5 –1.5 to 0 ≥0
Mali:
ASMR
=
23.10
Central African Republic:
ASMR
=
23.51
Sudan:
ASMR
=
25.24
ASMR in 2019 (per 100
000 population)
B
EAPC of ASMR
C
Change in deaths, %
A
Cook Islands:
EAPC = –10.23 The percentage of relative change in
deaths of neonatal preterm birth
between 1990 and 2019 (A),
age-standardized mortality rates
(ASMRs) of neonatal preterm birth in
2019 (B), and estimated annual
percentage change (EAPCs) of
ASMRs of neonatal preterm birth
from 1990 to 2019 (C) are reported.
Global, Regional, and National Incidence and Mortality of Neonatal Preterm Birth, 1990-2019 Original Investigation Research
jamapediatrics.com (Reprinted) JAMA Pediatrics Published online May 31, 2022 E7
Downloaded From: https://jamanetwork.com/ on 06/02/2022
P< .001) and UHCI in 2019 = 0.38; P< .001) (Figure 3A and
B). Surprisingly, a significant negative correlation was de-
tected between EAPC of ASMR of neonatal preterm birth and
SDI in 2019 = −0.42; P< .001) and UHCI in 2019 = −0.47;
P< .001) (Figure 3C and D).
Discussion
To our knowledge, this is the first comprehensive assessment
of the global landscape, long-term trends, and regional differ-
ences in the incidence and mortality of neonatal preterm
birth, as well as the association with socioeconomic status at
the national level, using data from the 2019 GBD study. In this
study, we found that the global ASIR and ASMR of neonatal
preterm birth decreased by a mean of 0.19% and 1.52% per
year from 1990 to 2019, respectively. Meanwhile, the global
absolute number of incident cases and deaths of neonatal pre-
term birth also decreased by 5.26% and 47.71% worldwide in
this period, respectively. For SDI regions, the ASIRs of neona-
tal preterm birth increased in high-SDI regions by a mean of
0.25% per year from 1990 to 2019. The ASMR of neonatal pre-
term birth increased by a mean of 2.09% per year in Southern
Sub-Saharan Africa in this period. Oceania experienced the
largest increase both in the number of incident cases (82.72%)
and deaths (60.39%) of neonatal preterm birth. Notably, we
found a positive association of EAPC of ASIR with SDI or UHCI
in 2019 and a negative association of EAPC of ASMR with SDI
or UHCI in 2019 at the national level.
Preterm birth is an important perinatal health problem,
contributing to increased mortality risk of children younger
than 5 years directly and maternal mortality indirectly.
9,14,15
Thus, reducing the incidence and mortality of preterm birth
is significant. A better understanding of the incidence and mor-
tality of preterm birth at the regional and national levels is
needed to improve access to effective obstetric and neonatal
care. In line with the decreasing trend in the global preterm
birth rate,
3
this current study found a decreasing trend in the
ASIR and ASMR of neonatal preterm birth worldwide. This is
largely attributed to improvements in maternal and newborn
health care.
16,17
Infant mortality from preterm birth can be re-
duced through interventions delivered to the birthing parent
before or during pregnancy and to the preterm infant after
birth.
4
The progress in the frequency of the presence of a skilled
birth attendant at birth in many countriespresents a major op-
portunity to reduce intrapartum stillbirth and neonatal
mortality.
16
In addition, high-quality health care for female in-
dividuals is also essential in the prevention of neonatal pre-
term birth.
2
Finally, improvements in nutritional status and
medical interventions for reducing preterm birth are also ben-
eficial for reducing the incidence and mortality of preterm
birth.
16
This study found that the ASIRs and ASMRs of neonatal
preterm birth varied significantly across regions and nations.
We found an increasing trend in the ASIR and a decreasing
trend in the ASMR in high-SDI regions between 1990 and 2019,
which was especially common in high-income countries, such
as Greece, Bahrain, Japan, the UK, and the US. However, this
study observed opposite trends in the ASIR and ASMR in some
low-income countries: the ASMR of neonatal preterm birth in-
creased but the ASIR of neonatal preterm birth decreased in
Southern Sub-Saharan Africa. Similar to our findings, several
previous studies reported that the incidence of preterm birth
increased in high-income countries in the past 2 decades.
3,8,18,19
Several possible factors contributing to but not completely ex-
plaining this increasing trend in the ASIR of neonatal preterm
Figure 3. Estimated Annual Percentage Changes (EAPCs) of Age-StandardizedIncidence Rates (ASIRs)
and Age-Standardized Mortality Rates (ASMRs) in Neonatal Preterm Birth at the Country and Territorial Levels
ρ= 0.41; P<.001
ρ= –0.42; P<.001 ρ= –0.47; P<.001
ρ= 0.38; P<.001
EAPC of ASIR
4
3
2
1
0
–1
–2
–3
SDI in 2019
Incidence of neonatal preterm birth
A
0 0.2 0.4 0.6 0.8 1.0
EAPC of ASIR
4
3
2
1
0
–1
–2
–3
UHCI in 2019
0 20 40 60 80 100
EAPC of ASMR
4
2
0
–2
–4
–6
–8
–10
SDI in 2019
Mortality of neonatal preterm birth
B
0 0.2 0.4 0.6 0.8 1.0
EAPC of ASMR
4
2
0
–2
–4
–6
–8
–10
UHCI in 2019
0 20 40 60 80 100
1000 000
750000
500000
25000
Incident cases
in 2019
1000 000
750000
500000
25000
Incident cases
in 2019
60000
45000
30000
15000
Deaths in
2019
60000
45000
30000
15000
Deaths in
2019 The incident cases and deaths of
neonatal preterm birth from 204
countries and territories in 2019 are
represented by circles. The size of the
circles increased with the incident
cases or deaths of neonatal preterm
birth. The ρ indices and Pvalues were
derived from Pearson correlation
analysis. SDI indicates
sociodemographic index;
UHCI, universal health coverage
index.
Research Original Investigation Global, Regional, and National Incidence and Mortality of Neonatal Preterm Birth, 1990-2019
E8 JAMA Pediatrics Published online May 31, 2022 (Reprinted) jamapediatrics.com
Downloaded From: https://jamanetwork.com/ on 06/02/2022
birth include increasing rates of multiple births, increases in the
proportion of births among individuals older than 34 years,
greater use of assisted reproduction techniques, and changes
in clinical practices, such as greater use of elective cesarean
delivery.
9,20,21
For example, the increasing age of individuals
giving birth in North America causes more maternal compli-
cations and cesarean deliveries and ultimately leads to an in-
creased risk of preterm birth.
9
In addition, the increasing use
of ultrasonography rather than the date of the last menstrual
period to estimate gestational age may have resulted in larger
numbers of births being classified as preterm.
9
In high-income
countries, the reduction in mortality rates in infants who were
born preterm has been driven largely byimproved maternal and
newborn health care.
4
One previous study reported that pre-
term survival rates have increased in high-income countries,
while preterm newborns still die because of a lack of adequate
newborn care in many low-income and middle-income
countries.
2
Almost all births are attended by skilled staff and 50%
of the neonates of less than 24 weeks’ gestation survive in high-
income countries, whereas even the neonates older than 32
weeks’ gestation have only a 50% chance of survival owing to
lack of available resources and/orlow quality of specialized c are
in low-income countries.
22
In high-income countries, admin-
istration of antenatal steroids is standard care for birthing par-
ents with anticipated preterm labor,which has been verified to
be very effective in preventingneonatal mortality; however, the
coverage of antenatal steroid therapy remains low in low- and
middle-income countries.
23
In addition, intrauterine infection
or lack of availability of drugs, such as tocolytic agents, might
contribute to an increased risk of preterm birth and deaths of
neonatal preterm birth in low-income countries.
9
Thus, the de-
velopment of interventions to reduce neonatalpreterm birth is
urgently needed for all countries, especially low-incomecoun-
tries where the incidence of neonatal preterm birth is high and
the trend in mortality of neonatal preterm birth is increasing.
These findings highlight the urgent need for discovery re-
search into the underlying mechanisms of neonatal preterm
birth and the development of innovative interventions.
Limitations
This current study comprehensively assessed the global land-
scape, long-term trends, and regional differences in the inci-
dence and mortality of neonatal preterm birth as well as the
association with socioeconomic status using data from GBD
estimates, which fill a gap where actual data on disease bur-
den are sparse or unavailable. However, several limitations
should be noted. First, the availability of data and the quality
of available data limited the accuracy and robustness of the
estimates of the incidence of mortality of neonatal preterm
birth in the modeling, which might lead to bias when na-
tional surveillance and population-based studies were lack-
ing. Second, data of gestational ages were not available in the
GBD study; thus, we cannot further analyze the trends in in-
cidence and mortality of neonatal preterm birth according to
different gestational ages. Third, EAPC in ASIRs and ASMRs as
well as the relative changein the number of inc ident cases and
deaths were used to assess its long-term trends from 1990 to
2019, which might mask the recent short-term trends that re-
flected the effectiveness of the recent prevention interven-
tions of preterm birth. Finally, the contribution of the causes
of preterm birth is unknown globally.
Conclusions
In summary,the global ASIR and ASMR of preterm birth gradu-
ally decreased from 1990 to 2019, while the ASIR increased in
high SDI region and the ASMR increased in Southern Sub-
Saharan Africa in this period. Preterm birth remains a crucial
issue in children, both in high- and low-resource countries.
Thus, efforts to reduce both the incidence and mortality of pre-
term births are essential worldwide.
ARTICLE INFORMATION
Accepted for Publication: March 9, 2022.
Published Online: May 31, 2022.
doi:10.1001/jamapediatrics.2022.1622
Open Access: This is an open access article
distributed under the terms of the CC-BY License.
©2022CaoGetal.JAMA Pediatrics.
Author Contributions: Dr M. Liu had full access to
all of the data in the study and takes responsibility
for the integrity of the data and the accuracy of the
data analysis.
Concept and design: All authors.
Acquisition, analysis, or interpretation of data: Cao.
Drafting of the manuscript: Cao.
Critical revision of the manuscript for important
intellectual content: All authors.
Statistical analysis: Cao, M. Liu.
Obtained funding: All authors.
Administrative, technical, or material support:
All authors.
Supervision: All authors.
Conflict of Interest Disclosures: None reported.
Funding/Support: This work was funded by
National Key R&D Program of China (grant
2021ZD0114104).
Role of the Funder/Sponsor:The funder had no
role in the design and conduct of the study;
collection, management, analysis, and
interpretation of the data; preparation, review, or
approval of the manuscript; and decision to submit
the manuscript for publication.
REFERENCES
1. World Health Organization. Preterm birth.
Published February 19, 2018.Accessed January 1,
2022. https://www.who.int/news-room/fact-
sheets/detail/preterm-birth
2. Chawanpaiboon S, Vogel JP, Moller AB, et al.
Global, regional, and national estimates of levels of
preterm birth in 2014: a systematic review and
modelling analysis. Lancet Glob Health. 2019;7(1):
e37-e46. doi:10.1016/S2214-109X(18)30451-0
3. Goldenberg RL, Culhane JF, Iams JD, Romero R.
Epidemiology and causes of preterm birth. Lancet.
2008;371(9606):75-84. doi:10.1016/S0140-6736
(08)60074-4
4. World Health Organization. WHO
recommendations on interventions to improve
preterm birth outcomes. Published November 1,
2015. Accessed January 1, 2021. https://www.who.
int/publications/i/item/9789241508988
5. GBD 2019 Diseases and Injuries Collaborators.
Global burden of 369 diseases and injuries in 204
countries and territories, 1990-2019: a systematic
analysis for the Global Burden of Disease Study
2019. Lancet. 2020;396(10258):1204-1222. doi:10.
1016/S0140-6736(20)30925-9
6. GBD 2017 Disease and Injury Incidence and
Prevalence Collaborators. Global, regional, and
national incidence, prevalence, and years lived with
disability for 354 diseases and injuries for 195
countries and territories, 1990-2017: a systematic
analysis for the Global Burden of Disease Study
2017. Lancet. 2018;392(10159):1789-1858. doi:10.
1016/S0140-6736(18)32279-7
7. GBD 2017 Causes of Death Collaborators. Global,
regional, and national age-sex-specific mortality for
Global, Regional, and National Incidence and Mortality of Neonatal Preterm Birth, 1990-2019 Original Investigation Research
jamapediatrics.com (Reprinted) JAMA Pediatrics Published online May 31, 2022 E9
Downloaded From: https://jamanetwork.com/ on 06/02/2022
282 causes of death in 195 countries and territories,
1980-2017: a systematicanalysis for the Global
Burden of Disease Study 2017. Lancet. 2018;392
(10159):1736-1788. doi:10.1016/S0140-6736(18)
32203-7
8. Blencowe H, Cousens S, Oestergaard MZ, et al.
National, regional, and worldwide estimates of
preterm birth rates in the year 2010 with time
trends since 1990 for selected countries:
a systematic analysis and implications. Lancet.
2012;379(9832):2162-2172. doi:10.1016/S0140-6736
(12)60820-4
9. Beck S, Wojdyla D, Say L, et al. The worldwide
incidence of preterm birth: a systematic review of
maternal mortality and morbidity. Bull WorldHealth
Organ. 2010;88(1):31-38. doi:10.2471/BLT.08.062554
10. Global Health Data Exchange. Accessed
January 1, 2021. https://ghdx.healthdata.org/
11. Global Burden of Disease Collaborative
Network. Global Burden of Disease Study 2019
(GBD 2019) UHC Effective Coverage Index
1990-2019.Institute for Health Metrics and
Evaluation; 2020. doi:10.6069/GT4K-3B35.
12. GBD 2019 Universal Health Coverage
Collaborators. Measuring universal health coverage
based on an index of effective coverage of health
services in 204 countries and territories,
1990-2019: a systematic analysis for the Global
Burden of Disease Study 2019. Lancet. 2020;396
(10258):1250-1284. doi:10.1016/S0140-6736(20)
30750-9
13. Liu Z, Jiang Y, YuanH, et al. The trends in
incidence of primary liver cancer caused by specific
etiologies: results from the Global Burden of
Disease Study 2016 and implications for liver cancer
prevention. J Hepatol. 2019;70(4):674-683. doi:10.
1016/j.jhep.2018.12.001
14. Di Renzo GC, Tosto V, Giardina I. The biological
basis and prevention of preterm birth. Best Pract
Res Clin Obstet Gynaecol. 2018;52:13-22. doi:10.
1016/j.bpobgyn.2018.01.022
15. Gülmezoglu AM, Say L, Betrán AP, Villar J,
Piaggio G. WHO systematic review of maternal
mortality and morbidity: methodological issues and
challenges. BMC Med Res Methodol. 2004;4:16.
doi:10.1186/1471-2288-4-16
16. Countdown to 2030 Collaboration. Countdown
to 2030: tracking progress towards universal
coverage for reproductive, maternal, newborn, and
child health. Lancet. 2018;391(10129):1538-1548.
doi:10.1016/S0140-6736(18)30104-1
17. ten Hoope-Bender P, de Bernis L, Campbell J,
et al. Improvement of maternal and newborn health
through midwifery. Lancet.2014;384(9949):1226-
1235. doi:10.1016/S0140-6736(14)60930-2
18. Callaghan WM, MacDorman MF, Rasmussen SA,
Qin C, Lackritz EM. The contribution of preterm
birth to infant mortality rates in the United States.
Pediatrics. 2006;118(4):1566-1573.doi:10.1542/
peds.2006-0860
19. Chang HH, Larson J, Blencowe H, et al; Born
Too Soon preterm preventionanalysis group.
Preventing preterm births: analysis of trends and
potential reductions with interventions in 39
countries with very high human development
index. Lancet. 2013;381(9862):223-234. doi:10.
1016/S0140-6736(12)61856-X
20. Martin JA, Hamilton BE, Osterman MJK,
Driscoll AK. Births: final data for 2019. Natl Vital
Stat Rep. 2021;70(2):1-51.
21. Goisis A, Remes H, Martikainen P, Klemetti R,
Myrskylä M. Medically assisted reproduction and
birth outcomes: a within-family analysis using
Finnish population registers. Lancet. 2019;393
(10177):1225-1232. doi:10.1016/S0140-6736(18)
31863-4
22. WHO. 15 million preterm births: Priorities for
action based on national, regional and global
estimates. In: Howson CP, Kinney MV,Lawn J, eds.
Born Too Soon: TheGlobal Action Report on Preterm
Birth. March of Dimes; 2012.
23. Mwansa-Kambafwile J, Cousens S, Hansen T,
Lawn JE. Antenatal steroids in preterm labour for
the prevention of neonatal deaths due to
complications of preterm birth. Int J Epidemiol.
2010;39 suppl 1(suppl 1):i122-i133. doi:10.1093/ije/
dyq029
Research Original Investigation Global, Regional, and National Incidence and Mortality of Neonatal Preterm Birth, 1990-2019
E10 JAMA Pediatrics Published online May 31, 2022 (Reprinted) jamapediatrics.com
Downloaded From: https://jamanetwork.com/ on 06/02/2022
... Infants born prematurely, defined as less than 37 weeks gestation, are at increased risk of morbidity and mortality. 1 There were 15.2 million cases of neonatal preterm birth in 2019, and preterm birth remains a leading cause of death worldwide during the neonatal period. 1 The risks associated with preterm birth include respiratory distress syndrome, bronchopulmonary dysplasia, necrotizing enterocolitis, sepsis, retinopathy of prematurity, and intraventricular hemorrhage and are dependent upon the degree of prematurity and the extent of low birth weight. [2][3][4][5] The recommended nutrition source for preterm infants is breast milk. ...
... 1 There were 15.2 million cases of neonatal preterm birth in 2019, and preterm birth remains a leading cause of death worldwide during the neonatal period. 1 The risks associated with preterm birth include respiratory distress syndrome, bronchopulmonary dysplasia, necrotizing enterocolitis, sepsis, retinopathy of prematurity, and intraventricular hemorrhage and are dependent upon the degree of prematurity and the extent of low birth weight. [2][3][4][5] The recommended nutrition source for preterm infants is breast milk. ...
Article
Full-text available
Objectives Breast milk is the recommended nutritional source for newborns and has been associated with decreased morbidity in low‐birth‐weight and preterm infants. In situations where breast milk is not available, donor breast milk is an alternative. Milk banking is becoming increasingly common worldwide to meet this need. Although the benefits of donor breast milk for the recipient infant are well established, the health impact on the breast milk donor and the infant of the breast milk donor is an area of current research. We aim to synthesize and evaluate the available evidence regarding the impact of donating breast milk on the health, lactation, and well‐being of the breast milk donor, and the health and growth of the infant of the breast milk donor. Methods We will search electronic databases, grey literature, and the websites of relevant international organizations. We will include studies that involve lactating women and their infants, healthy or with health conditions, who donate breast milk, without restrictions on study date, language, or study design. If sufficient homogeneity exists between studies, we will complete meta‐analyses. We will evaluate the risk of bias using the Risk of Bias tool or the Cochrane Risk of Bias in Non‐Randomized Studies tool. We will evaluate the overall certainty of the evidence using the Grading of Recommendations Assessment, Development, and Evaluation approach. Conclusion In this systematic review and meta‐analysis, we will summarize the current literature regarding the effects of human milk donation on human milk donors and their infants.
... Preterm birth, defined as delivery before 37 weeks of gestation, is a leading cause of neonatal morbidity and mortality worldwide [1][2][3][4]. The prematurity status places these infants at a significant disadvantage, primarily due to the underdevelopment of their organ systems, including the immune system. ...
... The inclusion criteria for this study comprised: (1) preterm newborns with a gestational age (GA) including extremely preterm (less than 28 weeks), very preterm (28-31 weeks), and moderate to late preterm (32-36 weeks) infants; (2) newborns that had measurements for inflammatory markers and laboratory parameters required to determine the NLR, dNLR, PLR, and NLPR. Conversely, the exclusion criteria were distinctly defined to maintain the study's focus and integrity: (1) the presence of severe congenital anomalies, particularly those affecting the cardiac, pulmonary, or central nervous systems, due to their potential independent impact laboratory studies; (2) neonates diagnosed with genetic syn-dromes, given the complex interplay between genetic factors and neonatal health outcomes; ...
Article
Full-text available
Background: Premature newborns are at a significant risk for Systemic Inflammatory Response Syndrome SIRS, a condition associated with high morbidity and mortality. This study aimed to evaluate the predictive and diagnostic capability of laboratory markers like Neutrophil to Lymphocyte Ratio (NLR), derived Neutrophil to Lymphocyte Ratio (dNLR), Platelet-to-Lymphocyte Ratio (PLR), and Neutrophil-to-Lymphocyte-to-Platelet Ratio (NLPR) in diagnosing SIRS in premature newborns. Methods: Premature newborns with and without SIRS were evaluated in a prospective design during a one-year period. Among 136 newborns, early and 72 h post-birth analyses were performed. Results: At 24 h, NLR’s cutoff value was 8.69, yielding sensitivity and specificity rates of 52.77% and 83.47% (p = 0.0429), respectively. The dNLR showed a cutoff of 5.61, with corresponding rates of 63.27% and 84.15% (p = 0.0011), PLR had a cutoff of 408.75, with rates of 51.89% and 80.22% (p = 0.1026), and NLPR displayed a cutoff of 0.24, with rates of 75.85% and 86.70% (p = 0.0002). At 72 h, notable sensitivity and specificity improvements were observed, particularly with NLPR having a cutoff of 0.17, showing sensitivity of 77.74% and specificity of 95.18% (p < 0.0001). NLR above the cutoff indicated a 33% increase in SIRS risk, with a hazard ratio (HR)of 1.33. The dNLR was associated with a twofold increase in risk (HR 2.04). NLPR demonstrated a significant, over threefold increase in SIRS risk (HR 3.56), underscoring its strong predictive and diagnostic value for SIRS development. Conclusion: Integrating these findings into clinical practice could enhance neonatal care by facilitating the early identification and management of SIRS, potentially improving outcomes for this vulnerable population.
... Approximately 15 million preterm infants are estimated to be born globally each year (1), making it one of the leading causes of mortality in children under the age of 5 years (2). Fortunately, the rapid advancement of intensive care technologies has significantly elevated the survival rates of premature infants. ...
... The EAPCs are measures of annual percentage change that may be utilized to assess the extent of the alteration in a variable over time [32,33], using the following model: ln (val) = b × year + a, where val is the value for age-standardized rates, b is the coefficient of the year, a is the intercept and year is the calendar year. For this study, the EAPCs and their 95% confidence intervals (95% CIs) of ASIRs, ASDRs, and ASRs of DALYs for AD and PD were calculated to reflect the temporal trends on a linear scale, respectively. ...
Article
Full-text available
Background Alzheimer’s disease and related dementias (ADRD) and Parkinson’s disease (PD), pose growing global health challenges. Socio-demographic and economic development acts paradoxically, complicating the process that determines how governments worldwide designate policies and allocate resources for healthcare. Methods We extracted data on ADRD and PD in 204 countries from the Global Burden of Disease 2019 database. Health disparities were estimated using the slope index of inequality (SII), and concentration index (CIX) based on the socio-demographic index. Estimated annual percentage changes (EAPCs) were employed to evaluate temporal trends. Results Globally, the SII increased from 255.4 [95% confidence interval (CI), 215.2 to 295.5)] in 1990 to 559.3 (95% CI, 497.2 to 621.3) in 2019 for ADRD, and grew from 66.0 (95% CI, 54.9 to 77.2) in 1990 to 132.5 (95% CI, 118.1 to 147.0) in 2019 for PD; CIX rose from 33.7 (95% CI, 25.8 to 41.6) in 1990 to 36.9 (95% CI, 27.8 to 46.1) in 2019 for ADRD, and expanded from 22.2 (95% CI, 21.3 to 23.0) in 1990 to 29.0 (95% CI, 27.8 to 30.3) in 2019 for PD. Age-standardized disability-adjusted life years displayed considerable upward trends for ADRD [EAPC = 0.43 (95% CI, 0.27 to 0.59)] and PD [0.34 (95% CI, 0.29 to 0.38)]. Conclusions Globally, the burden of ADRD and PD continues to increase with growing health disparities. Variations in health inequalities and the impact of socioeconomic development on disease trends underscored the need for targeted policies and strategies, with heightened awareness, preventive measures, and active management of risk factors.
... An investigation spanning from 1990 to 2019 that focused on the global, regional, and national incidences of and mortality associated with neonatal PTB revealed a noteworthy positive correlation between the prevalence of neonatal PTB and the sociodemographic index in 2019, as well as the universal health coverage index in 2019. This correlation was particularly pronounced in high-income countries, such as Greece, Bahrain, Japan, the United Kingdom, and the United States, which corroborates our findings [15]. ...
Article
Background The worldwide incidence of preterm births is increasing, and the risks of adverse outcomes for preterm infants significantly increase with shorter gestation, resulting in a substantial socioeconomic burden. Limited epidemiological studies have been conducted in China regarding the incidence and spatiotemporal trends of preterm births. Seasonal variations in risk indicate the presence of possible modifiable factors. Gender influences the risk of preterm birth. Objective This study aims to assess the incidence rates of preterm birth, very preterm birth, and extremely preterm birth; elucidate their spatiotemporal distribution; and investigate the risk factors associated with preterm birth. Methods We obtained data from the Guangdong Provincial Maternal and Child Health Information System, spanning from January 1, 2014, to December 31, 2021, pertaining to neonates with gestational ages ranging from 24 weeks to 42 weeks. The primary outcome measures assessed variations in the rates of different preterm birth subtypes over the course of the study, such as by year, region, and season. Furthermore, we examined the relationship between preterm birth incidence and per capita gross domestic product (GDP), simultaneously analyzing the contributing risk factors. Results The analysis incorporated data from 13,256,743 live births. We identified 754,268 preterm infants and 12,502,475 full-term infants. The incidences of preterm birth, very preterm birth, and extremely preterm birth were 5.69 per 100 births, 4.46 per 1000 births, and 4.83 per 10,000 births, respectively. The overall incidence of preterm birth increased from 5.12% in 2014 to 6.38% in 2021. The incidence of extremely preterm birth increased from 4.10 per 10,000 births in 2014 to 8.09 per 10,000 births in 2021. There was a positive correlation between the incidence of preterm infants and GDP per capita. In more developed economic regions, the incidence of preterm births was higher. Furthermore, adjusted odds ratios revealed that advanced maternal age, multiple pregnancies, and male infants were associated with an increased risk of preterm birth, whereas childbirth in the autumn season was associated with a protective effect against preterm birth. Conclusions The incidence of preterm birth in southern China exhibited an upward trend, closely linked to enhancements in the care capabilities for high-risk pregnant women and critically ill newborns. With the recent relaxation of China's 3-child policy, coupled with a temporary surge in advanced maternal age and multiple pregnancies, the risk of preterm birth has risen. Consequently, there is a pressing need to augment public health investments aimed at mitigating the risk factors associated with preterm birth, thereby alleviating the socioeconomic burden it imposes.
... India has the highest number of premature births in the world [1]. Developing countries including India have an incidence of retinopathy of prematurity (ROP) ranging from 38% to 47% in different regions of India [1][2][3]. ROP is a disorder of the development of retinal blood vessels in premature infants. Normally retinal vascularization starts from the optic disc to the ora serrata. ...
Article
Full-text available
Objectives: The objectives are to study the clinical course and outcomes of Zone I retinopathy of prematurity and also to study the indication of management and the factors affecting the choice of treatment modality. Methods: The present study was a prospective observational study conducted at the Department of Ophthalmology. All the neonates having Zone I retinopathy of prematurity (ROP) at presentation according to the International Classification of ROP classification were included in the study after obtaining permission from the institutional ethics committee and consent from parents. Results: In the present study, 526 neonates were screened and ROP was detected in 131 neonates with an incidence of 24.90%. Out of those 131, Zone I ROP was detected in 50 neonates, giving an incidence of 9.50%. Conclusion: In our study, Type 1 ROP has a variable course with 47.61% who initially had mild-looking disease developed Type 1 ROP requiring treatment. Hence, a proper timely follow-up is also important in these patients, we cannot exclude the probability of ROP based on the first examination, because when they are present, they are very preterm so vascularization is only until Zone I.
... Both biological and genetic factors may play a role. First, male children are more likely to be born prematurely, which signifies lower survival chances [26]. Second, the X chromosome carries more genes responsible for immune function, leaving male children with CAs more vulnerable to infections [27]. ...
Article
Background As one of the leading causes of child mortality, deaths due to congenital anomalies (CAs) have been a prominent obstacle to meet Sustainable Development Goal 3.2. Objective We conducted this study to understand the death burden and trend of under-5 CA mortality (CAMR) in Zhejiang, one of the provinces with the best medical services and public health foundations in Eastern China. Methods We used data retrieved from the under-5 mortality surveillance system in Zhejiang from 2012 to 2021. CAMR by sex, residence, and age group for each year was calculated and standardized according to 2020 National Population Census sex- and residence-specific live birth data in China. Poisson regression models were used to estimate the annual average change rate (AACR) of CAMR and to obtain the rate ratio between subgroups after adjusting for sex, residence, and age group when appropriate. Results From 2012 to 2021, a total of 1753 children died from CAs, and the standardized CAMR declined from 121.2 to 62.6 per 100,000 live births with an AACR of –9% (95% CI –10.7% to –7.2%; P<.001). The declining trend was also observed in female and male children, urban and rural children, and neonates and older infants, and the AACRs were –9.7%, –8.5%, –8.5%, –9.2%, –12%, and –6.3%, respectively (all P<.001). However, no significant reduction was observed in children aged 1-4 years (P=.22). Generally, the CAMR rate ratios for male versus female children, rural versus urban children, older infants versus neonates, and older children versus neonates were 1.18 (95% CI 1.08-1.30; P<.001), 1.20 (95% CI 1.08-1.32; P=.001), 0.66 (95% CI 0.59-0.73; P<.001), and 0.20 (95% CI 0.17-0.24; P<.001), respectively. Among all broad CA groups, circulatory system malformations, mainly deaths caused by congenital heart diseases, accounted for 49.4% (866/1753) of deaths and ranked first across all years, although it declined yearly with an AACR of –9.8% (P<.001). Deaths due to chromosomal abnormalities tended to grow in recent years, although the AACR was not significant (P=.90). Conclusions CAMR reduced annually, with cardiovascular malformations ranking first across all years in Zhejiang, China. Future research and practices should focus more on the prevention, early detection, long-term management of CAs and comprehensive support for families with children with CAs to improve their survival chances.
Article
Objectives We evaluated fetal cardiovascular physiology and mode of cardiac failure in premature miniature piglets on a pumped artificial placenta (AP) circuit. Methods Fetal pigs were cannulated via the umbilical vessels and transitioned to an AP circuit composed of a centrifugal pump and neonatal oxygenator and maintained in a fluid‐filled biobag. Echocardiographic studies were conducted to measure ventricular function, umbilical blood flow, and fluid status. In utero scans were used as control data. Results AP fetuses ( n = 13; 102±4d gestational age [term 115d]; 616 ± 139 g [g]; survival 46.4 ± 46.8 h) were tachycardic and hypertensive with initially supraphysiologic circuit flows. Increased myocardial wall thickness was observed. Signs of fetal hydrops were present in all piglets. Global longitudinal strain (GLS) measurements increased in the left ventricle (LV) after transition to the circuit. Right ventricle (RV) and LV strain rate decreased early during AP support compared with in utero measurements but recovered toward the end of the experiment. Fetuses supported for >24 h had similar RV GLS to in utero controls and significantly higher GLS compared to piglets surviving only up to 24 h. Conclusions Fetuses on a pump‐supported AP circuit experienced an increase in afterload, and redistribution of blood flow between the AP and systemic circulations, associated with elevated end‐diastolic filling pressures. This resulted in heart failure and hydrops. These preterm fetuses were unable to tolerate the hemodynamic changes associated with connection to the current AP circuit. To better mimic the physiology of the native placenta and preserve normal fetal cardiovascular physiology, further optimization of the circuit will be required.
Article
Full-text available
Background: In an era of shifting global agendas and expanded emphasis on non-communicable diseases and injuries along with communicable diseases, sound evidence on trends by cause at the national level is essential. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) provides a systematic scientific assessment of published, publicly available, and contributed data on incidence, prevalence, and mortality for a mutually exclusive and collectively exhaustive list of diseases and injuries. Methods: GBD estimates incidence, prevalence, mortality, years of life lost (YLLs), years lived with disability (YLDs), and disability-adjusted life-years (DALYs) due to 369 diseases and injuries, for two sexes, and for 204 countries and territories. Input data were extracted from censuses, household surveys, civil registration and vital statistics, disease registries, health service use, air pollution monitors, satellite imaging, disease notifications, and other sources. Cause-specific death rates and cause fractions were calculated using the Cause of Death Ensemble model and spatiotemporal Gaussian process regression. Cause-specific deaths were adjusted to match the total all-cause deaths calculated as part of the GBD population, fertility, and mortality estimates. Deaths were multiplied by standard life expectancy at each age to calculate YLLs. A Bayesian meta-regression modelling tool, DisMod-MR 2.1, was used to ensure consistency between incidence, prevalence, remission, excess mortality, and cause-specific mortality for most causes. Prevalence estimates were multiplied by disability weights for mutually exclusive sequelae of diseases and injuries to calculate YLDs. We considered results in the context of the Socio-demographic Index (SDI), a composite indicator of income per capita, years of schooling, and fertility rate in females younger than 25 years. Uncertainty intervals (UIs) were generated for every metric using the 25th and 975th ordered 1000 draw values of the posterior distribution. Findings: Global health has steadily improved over the past 30 years as measured by age-standardised DALY rates. After taking into account population growth and ageing, the absolute number of DALYs has remained stable. Since 2010, the pace of decline in global age-standardised DALY rates has accelerated in age groups younger than 50 years compared with the 1990-2010 time period, with the greatest annualised rate of decline occurring in the 0-9-year age group. Six infectious diseases were among the top ten causes of DALYs in children younger than 10 years in 2019: lower respiratory infections (ranked second), diarrhoeal diseases (third), malaria (fifth), meningitis (sixth), whooping cough (ninth), and sexually transmitted infections (which, in this age group, is fully accounted for by congenital syphilis; ranked tenth). In adolescents aged 10-24 years, three injury causes were among the top causes of DALYs: road injuries (ranked first), self-harm (third), and interpersonal violence (fifth). Five of the causes that were in the top ten for ages 10-24 years were also in the top ten in the 25-49-year age group: road injuries (ranked first), HIV/AIDS (second), low back pain (fourth), headache disorders (fifth), and depressive disorders (sixth). In 2019, ischaemic heart disease and stroke were the top-ranked causes of DALYs in both the 50-74-year and 75-years-and-older age groups. Since 1990, there has been a marked shift towards a greater proportion of burden due to YLDs from non-communicable diseases and injuries. In 2019, there were 11 countries where non-communicable disease and injury YLDs constituted more than half of all disease burden. Decreases in age-standardised DALY rates have accelerated over the past decade in countries at the lower end of the SDI range, while improvements have started to stagnate or even reverse in countries with higher SDI. Interpretation: As disability becomes an increasingly large component of disease burden and a larger component of health expenditure, greater research and development investment is needed to identify new, more effective intervention strategies. With a rapidly ageing global population, the demands on health services to deal with disabling outcomes, which increase with age, will require policy makers to anticipate these changes. The mix of universal and more geographically specific influences on health reinforces the need for regular reporting on population health in detail and by underlying cause to help decision makers to identify success stories of disease control to emulate, as well as opportunities to improve. Funding: Bill & Melinda Gates Foundation.
Article
Full-text available
Background Achieving universal health coverage (UHC) involves all people receiving the health services they need, of high quality, without experiencing financial hardship. Making progress towards UHC is a policy priority for both countries and global institutions, as highlighted by the agenda of the UN Sustainable Development Goals (SDGs) and WHO's Thirteenth General Programme of Work (GPW13). Measuring effective coverage at the health-system level is important for understanding whether health services are aligned with countries' health profiles and are of sufficient quality to produce health gains for populations of all ages. Methods Based on the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019, we assessed UHC effective coverage for 204 countries and territories from 1990 to 2019. Drawing from a measurement framework developed through WHO's GPW13 consultation, we mapped 23 effective coverage indicators to a matrix representing health service types (eg, promotion, prevention, and treatment) and five population-age groups spanning from reproductive and newborn to older adults (≥65 years). Effective coverage indicators were based on intervention coverage or outcome-based measures such as mortality-to-incidence ratios to approximate access to quality care; outcome-based measures were transformed to values on a scale of 0–100 based on the 2·5th and 97·5th percentile of location-year values. We constructed the UHC effective coverage index by weighting each effective coverage indicator relative to its associated potential health gains, as measured by disability-adjusted life-years for each location-year and population-age group. For three tests of validity (content, known-groups, and convergent), UHC effective coverage index performance was generally better than that of other UHC service coverage indices from WHO (ie, the current metric for SDG indicator 3.8.1 on UHC service coverage), the World Bank, and GBD 2017. We quantified frontiers of UHC effective coverage performance on the basis of pooled health spending per capita, representing UHC effective coverage index levels achieved in 2019 relative to country-level government health spending, prepaid private expenditures, and development assistance for health. To assess current trajectories towards the GPW13 UHC billion target—1 billion more people benefiting from UHC by 2023—we estimated additional population equivalents with UHC effective coverage from 2018 to 2023. Findings Globally, performance on the UHC effective coverage index improved from 45·8 (95% uncertainty interval 44·2–47·5) in 1990 to 60·3 (58·7–61·9) in 2019, yet country-level UHC effective coverage in 2019 still spanned from 95 or higher in Japan and Iceland to lower than 25 in Somalia and the Central African Republic. Since 2010, sub-Saharan Africa showed accelerated gains on the UHC effective coverage index (at an average increase of 2·6% [1·9–3·3] per year up to 2019); by contrast, most other GBD super-regions had slowed rates of progress in 2010–2019 relative to 1990–2010. Many countries showed lagging performance on effective coverage indicators for non-communicable diseases relative to those for communicable diseases and maternal and child health, despite non-communicable diseases accounting for a greater proportion of potential health gains in 2019, suggesting that many health systems are not keeping pace with the rising non-communicable disease burden and associated population health needs. In 2019, the UHC effective coverage index was associated with pooled health spending per capita (r=0·79), although countries across the development spectrum had much lower UHC effective coverage than is potentially achievable relative to their health spending. Under maximum efficiency of translating health spending into UHC effective coverage performance, countries would need to reach $1398 pooled health spending per capita (US$ adjusted for purchasing power parity) in order to achieve 80 on the UHC effective coverage index. From 2018 to 2023, an estimated 388·9 million (358·6–421·3) more population equivalents would have UHC effective coverage, falling well short of the GPW13 target of 1 billion more people benefiting from UHC during this time. Current projections point to an estimated 3·1 billion (3·0–3·2) population equivalents still lacking UHC effective coverage in 2023, with nearly a third (968·1 million [903·5–1040·3]) residing in south Asia. Interpretation The present study demonstrates the utility of measuring effective coverage and its role in supporting improved health outcomes for all people—the ultimate goal of UHC and its achievement. Global ambitions to accelerate progress on UHC service coverage are increasingly unlikely unless concerted action on non-communicable diseases occurs and countries can better translate health spending into improved performance. Focusing on effective coverage and accounting for the world's evolving health needs lays the groundwork for better understanding how close—or how far—all populations are in benefiting from UHC. Funding Bill & Melinda Gates Foundation.
Article
Full-text available
Background The Global Burden of Diseases, Injuries, and Risk Factors Study 2017 (GBD 2017) includes a comprehensive assessment of incidence, prevalence, and years lived with disability (YLDs) for 354 causes in 195 countries and territories from 1990 to 2017. Previous GBD studies have shown how the decline of mortality rates from 1990 to 2016 has led to an increase in life expectancy, an ageing global population, and an expansion of the non-fatal burden of disease and injury. These studies have also shown how a substantial portion of the world's population experiences non-fatal health loss with considerable heterogeneity among different causes, locations, ages, and sexes. Ongoing objectives of the GBD study include increasing the level of estimation detail, improving analytical strategies, and increasing the amount of high-quality data. Methods We estimated incidence and prevalence for 354 diseases and injuries and 3484 sequelae. We used an updated and extensive body of literature studies, survey data, surveillance data, inpatient admission records, outpatient visit records, and health insurance claims, and additionally used results from cause of death models to inform estimates using a total of 68 781 data sources. Newly available clinical data from India, Iran, Japan, Jordan, Nepal, China, Brazil, Norway, and Italy were incorporated, as well as updated claims data from the USA and new claims data from Taiwan (province of China) and Singapore. We used DisMod-MR 2.1, a Bayesian meta-regression tool, as the main method of estimation, ensuring consistency between rates of incidence, prevalence, remission, and cause of death for each condition. YLDs were estimated as the product of a prevalence estimate and a disability weight for health states of each mutually exclusive sequela, adjusted for comorbidity. We updated the Socio-demographic Index (SDI), a summary development indicator of income per capita, years of schooling, and total fertility rate. Additionally, we calculated differences between male and female YLDs to identify divergent trends across sexes. GBD 2017 complies with the Guidelines for Accurate and Transparent Health Estimates Reporting. Findings Globally, for females, the causes with the greatest age-standardised prevalence were oral disorders, headache disorders, and haemoglobinopathies and haemolytic anaemias in both 1990 and 2017. For males, the causes with the greatest age-standardised prevalence were oral disorders, headache disorders, and tuberculosis including latent tuberculosis infection in both 1990 and 2017. In terms of YLDs, low back pain, headache disorders, and dietary iron deficiency were the leading Level 3 causes of YLD counts in 1990, whereas low back pain, headache disorders, and depressive disorders were the leading causes in 2017 for both sexes combined. All-cause age-standardised YLD rates decreased by 3·9% (95% uncertainty interval [UI] 3·1–4·6) from 1990 to 2017; however, the all-age YLD rate increased by 7·2% (6·0–8·4) while the total sum of global YLDs increased from 562 million (421–723) to 853 million (642–1100). The increases for males and females were similar, with increases in all-age YLD rates of 7·9% (6·6–9·2) for males and 6·5% (5·4–7·7) for females. We found significant differences between males and females in terms of age-standardised prevalence estimates for multiple causes. The causes with the greatest relative differences between sexes in 2017 included substance use disorders (3018 cases [95% UI 2782–3252] per 100 000 in males vs s1400 [1279–1524] per 100 000 in females), transport injuries (3322 [3082–3583] vs 2336 [2154–2535]), and self-harm and interpersonal violence (3265 [2943–3630] vs 5643 [5057–6302]). Interpretation Global all-cause age-standardised YLD rates have improved only slightly over a period spanning nearly three decades. However, the magnitude of the non-fatal disease burden has expanded globally, with increasing numbers of people who have a wide spectrum of conditions. A subset of conditions has remained globally pervasive since 1990, whereas other conditions have displayed more dynamic trends, with different ages, sexes, and geographies across the globe experiencing varying burdens and trends of health loss. This study emphasises how global improvements in premature mortality for select conditions have led to older populations with complex and potentially expensive diseases, yet also highlights global achievements in certain domains of disease and injury.
Article
Full-text available
This paper estimated mortality for 282 causesof death in 195 countries from 1980 to 2017, adding 18 causes to its estimates compared to GBD 2016. In 2017, the GBD study added numerous data sources, including 127 country-years of vital registration data and 502 country-years of cancer registry data.
Article
Full-text available
Background Preterm birth is the leading cause of death in children younger than 5 years worldwide. Although preterm survival rates have increased in high-income countries, preterm newborns still die because of a lack of adequate newborn care in many low-income and middle-income countries. We estimated global, regional, and national rates of preterm birth in 2014, with trends over time for some selected countries. Methods We systematically searched for data on preterm birth for 194 WHO Member States from 1990 to 2014 in databases of national civil registration and vital statistics (CRVS). We also searched for population-representative surveys and research studies for countries with no or limited CRVS data. For 38 countries with high-quality data for preterm births in 2014, data are reported directly. For countries with at least three data points between 1990 and 2014, we used a linear mixed regression model to estimate preterm birth rates. We also calculated regional and global estimates of preterm birth for 2014. Findings We identified 1241 data points across 107 countries. The estimated global preterm birth rate for 2014 was 10·6% (uncertainty interval 9·0–12·0), equating to an estimated 14·84 million (12·65 million–16·73 million) live preterm births in 2014. 12· 0 million (81·1%) of these preterm births occurred in Asia and sub-Saharan Africa. Regional preterm birth rates for 2014 ranged from 13·4% (6·3–30·9) in North Africa to 8·7% (6·3–13·3) in Europe. India, China, Nigeria, Bangladesh, and Indonesia accounted for 57·9 million (41×4%) of 139·9 million livebirths and 6·6 million (44×6%) of preterm births globally in 2014. Of the 38 countries with high-quality data, preterm birth rates have increased since 2000 in 26 countries and decreased in 12 countries. Globally, we estimated that the preterm birth rate was 9×8% (8×3–10×9) in 2000, and 10×6% (9×0–12×0) in 2014. Interpretation Preterm birth remains a crucial issue in child mortality and improving quality of maternal and newborn care. To better understand the epidemiology of preterm birth, the quality and volume of data needs to be improved, including standardisation of definitions, measurement, and reporting. Funding WHO and the March of Dimes.
Article
Full-text available
Building upon the successes of Countdown to 2015, Countdown to 2030 aims to support the monitoring and measurement of women's, children's, and adolescents' health in the 81 countries that account for 95% of maternal and 90% of all child deaths worldwide. To achieve the Sustainable Development Goals by 2030, the rate of decline in prevalence of maternal and child mortality, stillbirths, and stunting among children younger than 5 years of age needs to accelerate considerably compared with progress since 2000. Such accelerations are only possible with a rapid scale-up of effective interventions to all population groups within countries (particularly in countries with the highest mortality and in those affected by conflict), supported by improvements in underlying socioeconomic conditions, including women's empowerment. Three main conclusions emerge from our analysis of intervention coverage, equity, and drivers of reproductive, maternal, newborn, and child health (RMNCH) in the 81 Countdown countries. First, even though strong progress was made in the coverage of many essential RMNCH interventions during the past decade, many countries are still a long way from universal coverage for most essential interventions. Furthermore, a growing body of evidence suggests that available services in many countries are of poor quality, limiting the potential effect on RMNCH outcomes. Second, within-country inequalities in intervention coverage are reducing in most countries (and are now almost non-existent in a few countries), but the pace is too slow. Third, health-sector (eg, weak country health systems) and non-health-sector drivers (eg, conflict settings) are major impediments to delivering high-quality services to all populations. Although more data for RMNCH interventions are available now, major data gaps still preclude the use of evidence to drive decision making and accountability. Countdown to 2030 is investing in improvements in measurement in several areas, such as quality of care and effective coverage, nutrition programmes, adolescent health, early childhood development, and evidence for conflict settings, and is prioritising its regional networks to enhance local analytic capacity and evidence for RMNCH.
Article
Objectives-This report presents 2019 data on U.S. births according to a wide variety of characteristics. Trends in fertility patterns and maternal and infant characteristics are described and interpreted. Methods-Descriptive tabulations of data reported on the birth certificates of the 3.75 million births that occurred in 2019 are presented. Data are presented for maternal age, livebirth order, race and Hispanic origin, marital status, tobacco use, prenatal care, source of payment for the delivery, method of delivery, gestational age, birthweight, and plurality. Selected data by mother's state of residence and birth rates by age are also shown. Trend data for 2010 through 2019 are presented for selected items. Trend data by race and Hispanic origin are shown for 2016-2019. Results-A total of 3,747,540 births were registered in the United States in 2019, down 1% from 2018. The general fertility rate declined from 2018 to 58.3 births per 1,000 women aged 15-44 in 2019. The birth rate for females aged 15-19 fell 4% between 2018 and 2019. Birth rates declined for women aged 20-34 and increased for women aged 35-44 for 2018-2019. The total fertility rate declined to 1,706.0 births per 1,000 women in 2019. Birth rates declined for both married and unmarried women from 2018 to 2019. The percentage of women who began prenatal care in the first trimester of pregnancy rose to 77.6% in 2019; the percentage of all women who smoked during pregnancy declined to 6.0%. The cesarean delivery rate decreased to 31.7% in 2019 (Figure 1). Medicaid was the source of payment for 42.1% of all births in 2019. The preterm birth rate rose for the fifth straight year to 10.23% in 2019; the rate of low birthweight was essentially unchanged from 2018 at 8.31%. Twin and triplet and higher-order multiple birth rates both declined in 2019 compared with 2018.
Article
Background: Children born after medically assisted reproduction are at higher risk of adverse birth outcomes than are children conceived naturally. We aimed to establish the extent to which this excess risk should be attributed to harmful effects of treatment or to pre-existing parental characteristics that confound the association. Methods: We used data from Finnish administrative registers covering a 20% random sample of households with at least one child aged 0–14 years at the end of 2000 (n=65 723). We analysed birthweight, gestational age, risk of low birthweight, and risk of preterm birth among children conceived both by medically assisted reproduction and naturally. First, we estimated differences in birth outcomes by mode of conception in the general population, using standard multivariate methods that controlled for observed factors (eg, multiple birth, birth order, and parental sociodemographic characteristics). Second, we used a sibling-comparison approach that has not been used before in medically assisted reproduction research. We compared children conceived by medically assisted reproduction with siblings conceived naturally and, thus, controlled for all observed and unobserved factors shared by siblings. Findings: Between 1995 and 2000, 2776 (4%) children in our sample were conceived by medically assisted reproduction; 1245 children were included in the sibling comparison. Children conceived by medically assisted reproduction had worse outcomes than did those conceived naturally, for all outcomes, even after adjustments for observed child and parental characteristics—eg, difference in birthweight of −60 g (95% CI −86 to −34) and 2·15 percentage point (95% CI 1·07 to 3·24) increased risk of preterm delivery. In the sibling comparison, the gap in birth outcomes was attenuated, such that the relation between medically assisted reproduction and adverse birth outcomes was statistically and substantively weak for all outcomes—eg, difference in birthweight of −31 g (95% CI −85 to 22) and 1·56 percentage point (95% CI −1·26 to 4·38) increased risk of preterm delivery. Interpretation: Children conceived by medically assisted reproduction face an elevated risk of adverse birth outcomes. However, our results indicate that this increased risk is largely attributable to factors other than the medically assisted reproduction treatment itself. Funding: European Research Council, the Academy of Finland, and the Signe and Ane Gyllenberg Foundation.
Article
Background & aims: Liver cancer is a common malignant neoplasm worldwide. The etiologies for liver cancer are diverse and the incidence trends of liver cancer caused by specific etiologies are rarely studied. We therefore aimed to determine the pattern of liver cancer incidence, as well as temporal trends. Methods: We collected detailed information on liver cancer etiology between 1990-2016, derived from the Global Burden of Disease study in 2016. Estimated annual percentage changes (EAPCs) in liver cancer age standardized incidence rate (ASR), by sex, region, and etiology, were calculated to quantify the temporal trends in liver cancer ASR. Results: Globally, incident cases of liver cancer increased 114.0% from 471,000 in 1990 to 1,007,800 in 2016. The overall ASR increased by an average 0.34% (95% CI 0.22%-0.45%) per year in this period. The ASR of liver cancer due to hepatitis B, hepatitis C, and other causes increased between 1990 and 2016. The corresponding EAPCs were 0.22 (95% CI 0.08-0.36), 0.57 (95% CI 0.48-0.66), and 0.51 (95% CI 0.41-0.62), respectively. The ASR of liver cancer due to reported alcohol use remained stable (EAPC = 0.10, 95% CI -0.06-0.25). This increasing pattern was heterogeneous across regions and countries. The most pronounced increases were generally observed in countries with a high socio-demographic index, including the Netherlands, the UK, and the USA. Conclusions: Liver cancer remains a major public health concern globally, though control of hepatitis B and C virus infections has contributed to the decreasing incidence in some regions. We observed an unfavorable trend in countries with a high socio-demographic index, suggesting that current prevention strategies should be reoriented, and much more targeted and specific strategies should be established in some countries to forestall the increase in liver cancer. Lay summary: Liver cancer is a common malignant neoplasm worldwide. The incidence patterns of liver cancer caused by different etiologies varied considerably across the world. In this study, we aim to determine the pattern of liver cancer incidence as well as the temporal trends, thereby facilitating the establishment of more tailored prevention strategies for liver cancer.
Article
The timing of birth is a critical determinant of perinatal and long term outcomes. Preterm birth is still the first cause of infant mortality and morbidity and unfortunately, rates of preterm birth remain high in both high and low-resource countries, ranging from 5 to18%. Preterm parturition is defined as syndrome, which can be induced through various factors such as infection, cervical pathology, uterine overdistension, progesterone deficiency, vascular alterations (utero-placental ischemia, decidual hemorrhage), maternal and fetal stress, allograft reaction, allergic phenomena and probably other several unknown factors. These various etiologies can lead to the pathological activation of a common pathway of decidua/fetal membranes activation leading to uterine contractility, cervical ripening and rupture of membranes. Moreover, the mechanisms responsible for these processes have been identified and involve receptors, chemokines and inflammatory cytokines. It is very important to understand the cellular and biochemical pathways responsible for preterm labor in order to identify, treat and prevent negative outcome in a timely manner. Clinicians and researchers play a key role in improve biochemical knowledge on preterm delivery, in identifying risk factors and shaping interventions which can address this complex syndrome.